Drugmakers Set to Raise US Prices on 500 Drugs in January
Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...
Stay updated with breaking news from Michael Erman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...
NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. The expected price hikes come as the pharmaceutical industry gears up for the Biden Administration to publish significantly discounted prices for 10 high-cost drugs in September, and continues to contend with higher inflation and manufacturing costs. Under President Joe Biden's Inflation Reduction Act (IRA), the government's Medicare health program ...
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...